Kolexia
Rey Philippe Oncologie hémato.
Rey Philippe
Oncologie hémato.
Centre Léon-Bérard
Lyon, France
85 Activités
229 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Myélome multiple Leucémie aigüe myéloïde Leucémie myéloïde Lymphome malin non hodgkinien Leucémies Lymphome B diffus à grandes cellules Lymphome B Tumeurs à plasmocytes

Collaborateurs

Voir plus
Nicolas Virelizier Emmanuelle
Nicolas Virelizier Emmanuelle
Centre Léon-Bérard, Lyon, France
Belhabri Amine
Belhabri Amine
Centre Léon-Bérard, Lyon, France
Michallet Anne-Sophie
Michallet Anne-Sophie
Centre Léon-Bérard, Lyon, France
Lebras Laure
Lebras Laure
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
Janssen
11 collaboration(s)
Dernière en 2023
Sanofi
9 collaboration(s)
Dernière en 2023
A+A
6 collaboration(s)
Dernière en 2022
Takeda Pharmaceutical
4 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
SUCCESSOR-1: A Phase 3, Two-Stage, Randomized, Multicenter, Open-Label Study Comparing Mezigdomide (CC-92480), Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Subjects With Relapsed or Refractory Multiple Myeloma (RRMM): SUCCESSOR-1
Essai Clinique (Celgene)   07 mars 2024
PASCA -MM: PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.
Essai Clinique (Centre Léon-Bérard)   20 février 2024
Long-Term Outcome of Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation (ASCT) - Impact of Therapeutic Strategy Following ASCT
65th ASH Annual Meeting Abstracts   02 novembre 2023
Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions.
Blood cancer journal   26 octobre 2023
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study.
Haematologica   01 octobre 2023
POSTER: MM-074 How can Different Therapeutic Strategies and Financial Resources Impact Outcomes After Autologous Stem Cell Transplantation in Myeloma? Study in France and Algeria
Proceedings of the Society of Hematologic Oncology 2023 Annual Meeting   01 septembre 2023
MM-074 How can Different Therapeutic Strategies and Financial Resources Impact Outcomes After Autologous Stem Cell Transplantation in Myeloma? Study in France and Algeria
Proceedings of the Society of Hematologic Oncology 2023 Annual Meeting   01 septembre 2023
PASCA: Study of Complications Related to Treatments in Adults Aged 18 to 65 Years Old Responding to a First Treatment in Oncology or Onco-hematology and Participating in the PASCA (PArcours de Santé au Cours du CAncer) Post-treatment Program.
Essai Clinique (Centre Léon-Bérard)   29 août 2023
OCAPI: An Interventional Prospective Study to Test the Feasibility of an Individualized Physical Activity Program in Patients Over 65 Years of Age With Hematologic Malignancies: the OCAPI Project.
Essai Clinique (Centre Léon-Bérard)   29 août 2023
Clinical outcome of therapy-related acute myeloid leukemia patients. Real-life experience in a University Hospital and a Cancer Center in France.
Cancer medicine   07 août 2023